Longevity & AgingScientists Launch Open Competition to Crown the Best Aging Biomarkers
Measuring how fast someone is biologically aging requires reliable biomarkers, but the field has been fragmented with dozens of competing clocks and markers lacking head-to-head comparison. Researchers from Harvard, Stanford, Cambridge, and Munich — working under the Biomarkers of Aging Consortium — have launched an open competition to systematically evaluate and rank aging biomarkers. The challenge invites teams worldwide to submit and test their tools against standardized criteria, with the goal of identifying which biomarkers best predict health outcomes, mortality, and the effects of interventions. Published in Nature Aging, this initiative could establish a shared benchmark for aging research, accelerating drug development, clinical trials, and personalized longevity medicine. It represents a rare collaborative push to bring scientific consensus to one of the most contested areas in geroscience.
